Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/01/2009 | CN101472559A suppository for hemorrhoid treatment |
07/01/2009 | CN101472558A Polymeric masticatory masses for cosmetic products |
07/01/2009 | CN101472557A Combination antihypertensive wafer |
07/01/2009 | CN101472556A Smoking withdrawal combination wafer |
07/01/2009 | CN101472555A Composition comprising an agent for stabilizing active substances in drinking water, effervescent mixture, method for the production thereof, and use thereof |
07/01/2009 | CN101467982A Brassiere paster for preventing and treating hyperplasia of mammary glands and preparation method thereof |
07/01/2009 | CN101467981A Patches for external use containing alpha-lipoic acid or derivates thereof as well as preparation method and application thereof |
07/01/2009 | CN101467980A Manidipine sustained-release capsules |
07/01/2009 | CN101467979A Ceftibuten sustained-release capsule |
07/01/2009 | CN101467978A Complete-water stomach dissolved type moisture-proofing film coating premix |
07/01/2009 | CN101467977A Oxycodone controlled release tablets |
07/01/2009 | CN101467976A Nifedipine pulsatile controlled release tablets |
07/01/2009 | CN101467975A Pinaverium bromide sustained release tablets |
07/01/2009 | CN101467974A Method for preparing esmolol dropping pills and use thereof |
07/01/2009 | CN101467973A Trapidil dispersible tablet |
07/01/2009 | CN101467972A Ceftibuten chewable tablet |
07/01/2009 | CN101467971A Dispersible tablet containing letrozole |
07/01/2009 | CN101467970A Soluble powder for treating livestock and poultry infected by sensitive bacteria |
07/01/2009 | CN101467969A Gastrodine nosal spray preparation |
07/01/2009 | CN101467968A Preparation for novel administration route of antiarrhythmic medicament |
07/01/2009 | CN101467967A Double-element solution type preparation for intravenous injection and intracerebral injection |
07/01/2009 | CN101467966A Antimicrobial type eye drop |
07/01/2009 | CN101467965A Eye drop containing carboxymethyl chitosan and prescription |
07/01/2009 | CN101467964A Long acting type eyedrops |
07/01/2009 | CN101467963A Eyedrops for treating xerophthalmia |
07/01/2009 | CN101467962A Nourishing type eye drop and prescription |
07/01/2009 | CN101467961A Nourishing and moisture-keeping type eye-nursing liquid and prescription |
07/01/2009 | CN101467960A Terbinafine hydrochloride emulsifiable paste and preparation method thereof |
07/01/2009 | CN101467959A Sustained-release composition and method for preparing the same |
07/01/2009 | CN101467958A Ceftibuten suspension |
07/01/2009 | CN101467957A Method for preparing amoxicillin floating tablets and use thereof |
07/01/2009 | CN101467956A Tramadol lipidosome gel for nose as well as preparation method and application thereof |
07/01/2009 | CN100506841C Method and carrier complexes for delivering molecules to cells |
07/01/2009 | CN100506311C Sustained delivery of an active agent using an implantable system |
07/01/2009 | CN100506286C Method, compounds and preparations for the identification of sentinel lymph nodes |
07/01/2009 | CN100506283C Plant substrates |
07/01/2009 | CN100506280C Uptake of macromolecules |
07/01/2009 | CN100506278C Topical composition, topical composition precursor, and methods for manufacturing and using |
07/01/2009 | CN100506249C Plaster for treating knocks and falls, and osteopathia |
07/01/2009 | CN100506234C Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn disease |
07/01/2009 | CN100506226C Compound famotidine chewing tablet preparation method |
07/01/2009 | CN100506222C Preparing method for controlled released type tablet tamsulosin hcl and the tablet thereof |
07/01/2009 | CN100506219C Notoginseng hemostatic and its preparing method |
07/01/2009 | CN100506218C Spider aroma preparation for treating diarrhea and preparation method thereof |
07/01/2009 | CN100506217C Ambroxol hydrochloride freeze-dried powder injection and preparing method thereof |
07/01/2009 | CN100506216C CefPiramide sodium powder for injection |
07/01/2009 | CN100506215C Cefathiamidine freeze-dried powder injection and preparing method thereof |
07/01/2009 | CN100506214C Gatifloxacin freeze-dried powder injection and preparing method thereof |
07/01/2009 | CN100506213C Lansoprazole freeze-dried powder for injection and preparing method thereof |
07/01/2009 | CN100506212C Sodium-NCTD freeze-dried powder for injection and preparing method thereof |
07/01/2009 | CN100506211C Urapidil hydrochloride freeze-dried powder for injection and preparing method thereof |
07/01/2009 | CN100506210C Ceftezole sodium powder injection and synthesizing method thereof |
07/01/2009 | CN100506209C Estrogen lipoplast preparing method |
07/01/2009 | CN100506208C Chansu-loaded nanoliposome and preparation method thereof |
07/01/2009 | CN100506207C Compound salvia miltiorrhiza delayed-release preparation and preparation method thereof |
07/01/2009 | CN100506060C One-step process for preparing gum |
07/01/2009 | CN100506051C Water soluble powders and tablets |
06/30/2009 | USRE40812 Liquid pharmaceutical composition for nasal administration comprising calcitonin or an acid addition salt thereof and a bioavailability enhancing agent selected from citric acid, citric acid salt, and combination thereof, wherein combined concentration of all bioavailability enhancing agents is 10-25 mM |
06/30/2009 | US7553919 Starch-vegetable oil graft copolymers and their biofiber composites, and a process for their manufacture |
06/30/2009 | US7553918 pH-sensitive polymer |
06/30/2009 | US7553913 Comprised of ethylene oxide and one or more other alkylene oxide(s); superior properties for medical and surgical applications; biocompatibility, substantial non-toxicity, water solubility, desirable handling properties (e.g., hardness, ductility, malleability) |
06/30/2009 | US7553872 Compounds and compositions for delivering active agents |
06/30/2009 | US7553870 Use of polyunsaturated fatty acid for the primary prevention of major cardiovascular events |
06/30/2009 | US7553865 Compounded with glyceryl monostearate, sorbitan monostearate, or stearyl alcohol; excellent use feeling and excellent absorbability, causes no phase separation into an oil layer and an aqueous layer, stability |
06/30/2009 | US7553844 Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors |
06/30/2009 | US7553835 foam or mousse; antifungal such as ketoconazole, lower alcohol, fatty alcohol, a quaternary or ethoxylated sorbitan surfactant, water, hydrocarbon gas propellant; jock itch, tinea, dandruff and sebborheic dermatitis |
06/30/2009 | US7553500 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms; selective estrogen receptor modulators |
06/30/2009 | US7553499 Sustained release tablet containing indapamide |
06/30/2009 | US7553498 Gastrointestinal disorders; anitulcer agents; mixture with surfactants and distingrat; cellulose ether enteric coating |
06/30/2009 | US7553497 Gelatin hard capsule enhancing the film strength |
06/30/2009 | US7553495 Liquid compositions comprising oxyalkylated polyglycerol esters |
06/30/2009 | US7553479 Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
06/30/2009 | CA2459399C Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
06/30/2009 | CA2422356C Suppository of retaining in lower region of rectum |
06/30/2009 | CA2407654C Liposome containing hydrophobic iodine compound |
06/30/2009 | CA2406833C Effervescent granules and methods for their preparation |
06/30/2009 | CA2387705C Stable pharmaceutical composition for oral use |
06/30/2009 | CA2373939C Generation of therapeutic microfoam |
06/30/2009 | CA2359318C Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups |
06/30/2009 | CA2236579C Methods and compositions for the delivery of monomeric proteins |
06/30/2009 | CA2211118C Stable lipid-comprising drug delivery complexes and methods for their production |
06/30/2009 | CA2198917C Sustained release of peptides from pharmaceutical compositions |
06/30/2009 | CA2188319C Coated products with potent anti-hiv and antimicrobial properties |
06/30/2009 | CA2158662C Sustained release veterinary composition |
06/30/2009 | CA2143486C Method of improving the immune response |
06/25/2009 | WO2009079537A1 Sustained release of nutrients in vivo |
06/25/2009 | WO2009079345A1 Process for recovering flunixin from pharmaceutical compositions |
06/25/2009 | WO2009078998A1 Therapeutic regimens for the treatment of immunoinflammatory disorders |
06/25/2009 | WO2009078994A1 Dispensing encapsulated fluids into body cavities or tissue |
06/25/2009 | WO2009078958A1 Coated pharmaceutical compositions |
06/25/2009 | WO2009078924A2 Mesoporous silica nanoparticles for biomedical applications |
06/25/2009 | WO2009078872A1 Orally disintegrating water soluble analgesic formulations and methods for production thereof |
06/25/2009 | WO2009078804A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
06/25/2009 | WO2009078803A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
06/25/2009 | WO2009078802A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
06/25/2009 | WO2009078756A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
06/25/2009 | WO2009078755A1 Drug delivery system for administration of a water soluble, cationic and amphiphilic pharmaceutically active substance |
06/25/2009 | WO2009078754A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
06/25/2009 | WO2009078447A1 Anti-norovirus agent, anti-influenza-virus agent, and anti-viral treatment method using each of the agents |
06/25/2009 | WO2009078034A2 Orally disintegrating tablets of ropinirole hydrochloride |